AI Article Synopsis
- Patients consider several important factors when deciding on genotyping tests for antiplatelet therapy, including convenience, physician recommendations, and prior explanations from medical staff.* -
- The study found that the majority of participants were influenced by their inclination towards clopidogrel due to reasons like less frequent dosing, lower costs, and reduced bleeding risks.* -
- The findings will help create a discrete choice experiment to better understand patient preferences and willingness to pay for genetic testing services.*
Article Abstract
Identify factors patients consider regarding genotyping test to guide choice of antiplatelet therapy. Patient's perception and attitude toward use of genotyping test was gathered according to an interview guide. Thematic analysis was conducted. A total of 14 patients were interviewed. The main factors found to influence uptake of genotyping test are, convenience of genotyping test (n = 4), physician's recommendation (n = 11), prior explanation of genetic testing by medical personnel (n = 5) and inclination toward clopidogrel, with three sub-factors; less frequent dosing (n = 3), lower cost (n = 7) and lower risk of bleeding (n = 9). This study provided the information needed to develop a discrete choice experiment to empirically quantify patients' preference and willingness to pay for genetic testing and to simulate uptake.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2217/fca-2020-0036 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!